Odyssey Therapeutics Inc (ODTX)

Sep 23, 2026

Top Odyssey Therapeutics (ODTX) Competitors 2026 - MarketBeat

Sep 23, 2026

Sep 23, 2026

Odyssey Therapeutics at Stifel forum: pipeline bets and cash runway By Investing.com - Investing.com Canada

Sep 23, 2026

Sep 23, 2026

Odyssey Therapeutics at Stifel forum: pipeline bets and cash runway - Investing.com

Sep 23, 2026

Sep 20, 2026

Odyssey Therapeutics, Inc.(NasdaqCM: ODTX) added to S&P Global BMI Index - marketscreener.com

Sep 20, 2026

Sep 17, 2026

Odyssey Therapeutics, Inc.(NasdaqCM: ODTX) added to Russell 3000 Growth Benchmark - marketscreener.com

Sep 17, 2026

Sep 16, 2026

Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum - GlobeNewswire

Sep 16, 2026

Sep 16, 2026

A biotech presentation is set for Sept. 23. Odyssey Therapeutics will take part online. - Stock Titan

Sep 16, 2026

Sep 13, 2026

Odyssey Therapeutics (ODTX) Banks Two More Years As Trials Multiply - Yahoo Finance

Sep 13, 2026

Sep 11, 2026

Odyssey Therapeutics, Inc. Common Stock (NASDAQ: ODTX) Stock Price, News & Analysis - kalkine.ca

Sep 11, 2026

Sep 10, 2026

Odyssey Therapeutics, Inc. (NASDAQ:ODTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Sep 10, 2026

Sep 09, 2026

Odyssey Therapeutics’ OD-001 Meets Key Endpoints in Ulcerative Colitis Trial - Minichart

Sep 09, 2026

Sep 09, 2026

symbol__ Stock Quote Price and Forecast - CNN

Sep 09, 2026

Sep 09, 2026

Oral ulcerative colitis drug at Odyssey (ODTX) put 27% of patients in remission—larger trials are planned - Stock Titan

Sep 09, 2026

Sep 09, 2026

Odyssey Therapeutics posts September 2026 presentation detailing OD-001 Phase 2a success, $433M cash runway into H2 2028 - TradingView

Sep 09, 2026

Sep 08, 2026

ODTX Price Today: Odyssey Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC

Sep 08, 2026

Sep 08, 2026

RIPK2 inhibitors reported in Odyssey Therapeutics patent - BioWorld News

Sep 08, 2026

Sep 04, 2026

Odyssey Therapeutics Hits $900M Valuation In Nasdaq Debut, Stock Climbs 13% Before Diving Lower - Stocktwits

Sep 04, 2026

Sep 03, 2026

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - Eastern Progress

Sep 03, 2026

Aug 31, 2026

Q3 Earnings Forecast for ODTX Issued By HC Wainwright - MarketBeat

Aug 31, 2026

Aug 27, 2026

Odyssey Therapeutics to Participate in Upcoming Investor Conferences - Moomoo

Aug 27, 2026

Aug 27, 2026

HC Wainwright Initiates Odyssey Therapeutics at Buy With $44 Price Target - Yahoo Finance

Aug 27, 2026

Aug 13, 2026

Odyssey Therapeutics (ODTX) Stock Trends and Sentiment 2026 - marketbeat.com

Aug 13, 2026

Aug 11, 2026

J.P. Morgan Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Raises Target Price to $29 - Moomoo

Aug 11, 2026

Aug 10, 2026

Odyssey Therapeutics (ODTX) Looks Fully Valued As Earnings And Evotec Deal Refocus Attention - Yahoo Finance

Aug 10, 2026

Aug 10, 2026

Odyssey Therapeutics (ODTX) Stock Looks Reasonable As AI Research News Lands - Sahm

Aug 10, 2026

Aug 08, 2026

Odyssey Therapeutics Ord Shs (Proposed) (ODTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 08, 2026

Aug 07, 2026

Evotec and Odyssey Forge AI-Powered Drug Discovery Pact Targeting Autoimmune Diseases - finance.biggo.com

Aug 07, 2026

Aug 07, 2026

Odyssey Therapeutics (NASDAQ:ODTX) Given New $29.00 Price Target at JPMorgan Chase & Co. - MarketBeat

Aug 07, 2026

Aug 06, 2026

EQS-News: Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - sharewise.com

Aug 06, 2026

Aug 06, 2026

Odyssey Therapeutics: Q2 Earnings Snapshot - marketscreener.com

Aug 06, 2026

Aug 06, 2026

Odyssey Therapeutics, Inc. Q2 2026: Revenue $0 EPS $(1.74) — 10-Q Summary - TradingView

Aug 06, 2026

Aug 06, 2026

Biotech Stocks At 52-Week HighsBVS, TVTX, ODTX, CRL Climb With Q2 Results, ACRS - RTTNews

Aug 06, 2026

Aug 06, 2026

Evotec and Odyssey Pair AI With Lab Tests for Immune Diseases - Stock Titan

Aug 06, 2026

Aug 06, 2026

Evotec Se and Odyssey Therapeutics, Inc. Enter Ai-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - marketscreener.com

Aug 06, 2026

Aug 06, 2026

Evotec : and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases - marketscreener.com

Aug 06, 2026

Aug 04, 2026

Odyssey Therapeutics (ODTX) Institutional Ownership 2026 - MarketBeat

Aug 04, 2026

Aug 04, 2026

Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

Aug 04, 2026

Aug 04, 2026

Odyssey Therapeutics reports Q2 2026 net loss $52.8M; cash $433.1M to fund into 2H 2028 - TradingView

Aug 04, 2026

Jul 27, 2026

Odyssey Therapeutics, Inc. Revenue Breakdown – NASDAQ:ODTX - TradingView

Jul 27, 2026

Jul 25, 2026

ODTX|Odyssey Therapeutics Ord Shs (Proposed)|Price:18.660|Chg%:+0.990 - TradingKey

Jul 25, 2026

Jul 14, 2026

Odyssey Therapeutics (ODTX) Earnings Date and Reports 2026 - MarketBeat

Jul 14, 2026

Jul 09, 2026

Enterprise value to EBITDA forward of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView

Jul 09, 2026

Jul 09, 2026

Enterprise value to revenue forward of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView

Jul 09, 2026